CCR5 blockade in rheumatoid arthritis: A randomised, double-blind, placebo-controlled clinical trial. Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'CCR5 blockade in rheumatoid arthritis: A randomised, double-blind, placebo-controlled clinical trial. Commentary'. Together they form a unique fingerprint.